MN Services Vermogensbeheer’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $45.7M | Sell |
361,639
-124,100
| -26% | -$16.4M | 0.34% | 60 |
|
|
2026
Q1 | $67.7M | Buy |
485,739
+2,900
| +0.6% | +$406K | 0.45% | 44 |
|
|
2025
Q4 | $59.3M | Buy |
482,839
+8,284
| +2% | +$1.01M | 0.36% | 60 |
|
|
2025
Q3 | $52.7M | Buy |
474,555
+8,500
| +2% | +$966K | 0.34% | 66 |
|
|
2025
Q2 | $51.7M | Buy |
466,055
+9,600
| +2% | +$1.02M | 0.36% | 58 |
|
|
2025
Q1 | $51.1M | Sell |
456,455
-35,700
| -7% | -$3.68M | 0.4% | 54 |
|
|
2024
Q4 | $45.5M | Buy |
492,155
+11,300
| +2% | +$1.02M | 0.31% | 64 |
|
|
2024
Q3 | $40.3M | Sell |
480,855
-11,900
| -2% | -$908K | 0.28% | 77 |
|
|
2024
Q2 | $33.8M | Sell |
492,755
-11,100
| -2% | -$741K | 0.24% | 87 |
|
|
2024
Q1 | $36.9M | Sell |
503,855
-87,800
| -15% | -$6.75M | 0.27% | 82 |
|
|
2023
Q4 | $47.9M | Sell |
591,655
-18,900
| -3% | -$1.47M | 0.43% | 63 |
|
|
2023
Q3 | $45.8M | Buy |
610,555
+10,900
| +2% | +$838K | 0.44% | 63 |
|
|
2023
Q2 | $46.2M | Sell |
599,655
-25,000
| -4% | -$1.99M | 0.43% | 63 |
|
|
2023
Q1 | $51.8M | Buy |
624,655
+18,900
| +3% | +$1.57M | 0.53% | 49 |
|
|
2022
Q4 | $52M | Sell |
605,755
-91,200
| -13% | -$7.22M | 0.58% | 45 |
|
|
2022
Q3 | $43M | Sell |
696,955
-40,100
| -5% | -$2.53M | 0.45% | 53 |
|
|
2022
Q2 | $45.6M | Sell |
737,055
-164,600
| -18% | -$10.2M | 0.42% | 56 |
|
|
2022
Q1 | $53.6M | Sell |
901,655
-57,500
| -6% | -$3.68M | 0.36% | 72 |
|
|
2021
Q4 | $69.6M | Buy |
959,155
+17,800
| +2% | +$1.23M | 0.41% | 62 |
|
|
2021
Q3 | $65.8M | Buy |
941,355
+19,900
| +2% | +$1.4M | 0.41% | 65 |
|
|
2021
Q2 | $53.5M | Buy |
+921,455
| New | +$61.5M | 0.42% | 63 |
|
|
2020
Q4 | $64.7M | Buy |
1,111,255
+12,800
| +1% | +$772K | 0.46% | 61 |
|
|
2020
Q3 | $69.4M | Buy |
1,098,455
+21,600
| +2% | +$1.5M | 0.55% | 47 |
|
|
2020
Q2 | $82.9M | Sell |
1,076,855
-15,800
| -1% | -$1.21M | 0.71% | 39 |
|
|
2020
Q1 | $81.7M | Sell |
1,092,655
-68,700
| -6% | -$4.75M | 0.91% | 31 |
|
|
2019
Q4 | $75.5M | Buy |
1,161,355
+36,700
| +3% | +$2.39M | 0.64% | 41 |
|
|
2019
Q3 | $71.3M | Buy |
1,124,655
+471,725
| +72% | +$30.8M | 0.66% | 41 |
|
|
2019
Q2 | $44.1M | Sell |
652,930
-68,000
| -9% | -$4.47M | 0.52% | 41 |
|
|
2019
Q1 | $46.9M | Buy |
720,930
+6,500
| +0.9% | +$432K | 0.54% | 41 |
|
|
2018
Q4 | $39.1M | Buy |
714,430
+505,855
| +243% | +$35.4M | 0.59% | 41 |
|
|
2018
Q3 | $16.1M | Sell |
208,575
-700
| -0.3% | -$52.9K | 0.38% | 57 |
|
|
2018
Q2 | $14.8M | Buy |
209,275
+3,700
| +2% | +$261K | 0.37% | 56 |
|
|
2018
Q1 | $15.5M | Buy |
205,575
+2,300
| +1% | +$183K | 0.4% | 51 |
|
|
2017
Q4 | $12.1M | Sell |
203,275
-12,200
| -6% | -$926K | 0.38% | 54 |
|
|
2017
Q3 | $17.5M | Sell |
215,475
-400
| -0.2% | -$30.6K | 0.46% | 43 |
|
|
2017
Q2 | $15.3M | Buy |
215,875
+180,694
| +514% | +$12M | 0.42% | 45 |
|
|
2017
Q1 | $2.23M | Buy |
35,181
+1,021
| +3% | +$71.8K | 0.43% | 45 |
|
|
2016
Q4 | $2.32M | Sell |
34,160
-294
| -0.9% | -$21.9K | 0.47% | 43 |
|
|
2016
Q3 | $2.73M | Sell |
34,454
-238
| -0.7% | -$19.3K | 0.54% | 38 |
|
|
2016
Q2 | $2.6M | Sell |
34,692
-1,431
| -4% | -$127K | 0.6% | 37 |
|
|
2016
Q1 | $2.91M | Buy |
+36,123
| New | +$3.26M | 0.68% | 30 |
|
Other funds holding GILD
MN Services Vermogensbeheer's GILD Position: Q2 2026 in Review
MN Services Vermogensbeheer reduced its Gilead Sciences (GILD) stake by 26% in Q2 2026, selling an estimated $16.4M and leaving 361,639 shares worth $45.7M. The position accounts for 0.34% of the portfolio, ranked #60.
MN Services Vermogensbeheer first reported a position in GILD in Q1 2016 and has held it in 41 quarters since. The position peaked at $82.9M in Q2 2020. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- MN Services Vermogensbeheer held 361,639 shares of Gilead Sciences worth $45.7M as of Q2 2026.
- MN Services Vermogensbeheer sold 124,100 Gilead Sciences shares in Q2 2026, an estimated $16.4M.
- Gilead Sciences made up 0.34% of MN Services Vermogensbeheer's portfolio in Q2 2026, its #60 holding.
- MN Services Vermogensbeheer first reported a position in Gilead Sciences in Q1 2016 and has held it in 41 quarters since.
- MN Services Vermogensbeheer's Gilead Sciences position peaked at $82.9M in Q2 2020.
- 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on MN Services Vermogensbeheer's 13F filing for Q2 2026, filed 31 Jul 2026.